<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Transl Oncol</journal-id><journal-id journal-id-type="iso-abbrev">Transl Oncol</journal-id><journal-id journal-id-type="pmc-domain-id">615</journal-id><journal-id journal-id-type="pmc-domain">transoncol</journal-id><journal-title-group><journal-title>Translational Oncology</journal-title></journal-title-group><issn pub-type="epub">1936-5233</issn><publisher><publisher-name>Neoplasia Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6462820</article-id><article-id pub-id-type="pmcid-ver">PMC6462820.1</article-id><article-id pub-id-type="pmcaid">6462820</article-id><article-id pub-id-type="pmcaiid">6462820</article-id><article-id pub-id-type="pmid">30986689</article-id><article-id pub-id-type="doi">10.1016/j.tranon.2019.03.003</article-id><article-id pub-id-type="publisher-id">S1936-5233(19)30023-3</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review article</subject></subj-group></article-categories><title-group><article-title><italic toggle="yes">Fusobacterium nucleatum</italic> Contributes to the Carcinogenesis of Colorectal Cancer by Inducing Inflammation and Suppressing Host Immunity</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Wu</surname><given-names initials="J">Jiao</given-names></name><xref rid="af0005" ref-type="aff">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="Q">Qing</given-names></name><xref rid="af0005" ref-type="aff">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fu</surname><given-names initials="X">Xiangsheng</given-names></name><email>drfuxs@gmail.com</email><xref rid="af0010" ref-type="aff">&#8224;</xref><xref rid="cr0005" ref-type="corresp">&#8270;</xref></contrib></contrib-group><aff id="af0005"><label>*</label>Department of Gastroenterology, the Affiliated Hospital of Southwest Medical University, Sichuan, China, 646000</aff><aff id="af0010"><label>&#8224;</label>Department of Gastroenterology, the Affiliated Hospital of North Sichuan Medical College, Nanchong City, China, 637000</aff><author-notes><corresp id="cr0005"><label>&#8270;</label>Address all correspondence to: Dr. Xiangsheng Fu, Department of Gastroenterology, the Affiliated Hospital of North Sichuan Medical College, Road Wenhua 63#, Region Shunqing, Nanchong City, China, 637000. <email>drfuxs@gmail.com</email></corresp></author-notes><pub-date pub-type="collection"><month>6</month><year>2019</year></pub-date><pub-date pub-type="epub"><day>12</day><month>4</month><year>2019</year></pub-date><volume>12</volume><issue>6</issue><issue-id pub-id-type="pmc-issue-id">332150</issue-id><fpage>846</fpage><lpage>851</lpage><history><date date-type="received"><day>15</day><month>1</month><year>2019</year></date><date date-type="rev-recd"><day>22</day><month>3</month><year>2019</year></date><date date-type="accepted"><day>26</day><month>3</month><year>2019</year></date></history><pub-history><event event-type="pmc-release"><date><day>12</day><month>04</month><year>2019</year></date></event><event event-type="pmc-live"><date><day>22</day><month>04</month><year>2019</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2019-06-29 08:56:14.197"><day>29</day><month>06</month><year>2019</year></date></event></pub-history><permissions><copyright-statement>&#169; 2019 The Authors</copyright-statement><copyright-year>2019</copyright-year><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="main.pdf"/><abstract id="ab0005"><p>The presence of <italic toggle="yes">Fusobacterium nucleatum</italic> (<italic toggle="yes">F. nucleatum</italic>) in the gut is associated with the development of colorectal cancer (CRC). <italic toggle="yes">F. nucleatum</italic> promotes tumor development by inducing inflammation and host immune response in the CRC microenvironment. Adhesion to the intestinal epithelium by the cell surface proteins FadA, Fap2 and RadD expressed by <italic toggle="yes">F. nucleatum</italic> can cause the host to produce inflammatory factors and recruit inflammatory cells, creating an environment which favors tumor growth. Furthermore, <italic toggle="yes">F. nucleatum</italic> can induce immune suppression of gut mucosa by suppressing the function of immune cells such as macrophages, T cells and natural killer cells, contributing the progression of CRC.</p></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY-NC-ND</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s0005"><title>Introduction</title><p id="p0005">The human intestine is home to more than 100 trillion microbes, forming a unique genome that changes with human nutrition status, geographic location, and even age <xref rid="bb0005" ref-type="bibr">[1]</xref>, <xref rid="bb0010" ref-type="bibr">[2]</xref>. Gut microbiota is in harmony with the human body, affecting human health and shaping the immune system of the host <xref rid="bb0015" ref-type="bibr">[3]</xref>. Imbalance in gut microbiota can lead to a variety of diseases, such as colitis, colorectal cancer (CRC), infection, food allergies, obesity, diabetes, cardiovascular atherosclerosis, bone metabolic diseases, Parkinson's and neurodegenerative diseases <xref rid="bb0020" ref-type="bibr">[4]</xref>.</p><p id="p0010">The colon has been colonized by the largest density of microorganisms <xref rid="bb0025" ref-type="bibr">[5]</xref>. Recent studies have reported that certain pathogenic bacteria in the colon are associated with CRC <xref rid="bb0025" ref-type="bibr">[5]</xref>, <xref rid="bb0030" ref-type="bibr">[6]</xref>. It's possible to screen CRC by detecting tumor-associated microorganisms in the feces <xref rid="bb0035" ref-type="bibr">[7]</xref>. CRC is the third most common tumor in the world, causing significant morbidity and mortality <xref rid="bb0015" ref-type="bibr">[3]</xref>. Unfortunately, the mechanism of this malignancy has not been fully explained, but inflammation is a recognized risk factor <xref rid="bb0040" ref-type="bibr">[8]</xref>. CRC is a chronic disease which can arise from other intestinal inflammatory conditions <xref rid="bb0030" ref-type="bibr">[6]</xref>.</p><p id="p0015">In recent years, many studies have been conducted on the correlation between inflammatory microorganisms and CRC. The occurrence of intestinal inflammatory diseases such as colitis is related to the metastasis of intestinal microbes <xref rid="bb0010" ref-type="bibr">[2]</xref>. Colitis occurs when microbes turn from a &#8216;eubiotic&#8217; to a &#8216;dysbiotic&#8217; state <xref rid="bb0010" ref-type="bibr">[2]</xref>. Chronic bacterial infection of the colon is a driving factor in tissue inflammation, increasing the risk of developing CRC <xref rid="bb0045" ref-type="bibr">[9]</xref>.</p></sec><sec id="s0010"><title>Gut Microbiota and Host Immunity</title><p id="p0020">Human bodies are constantly exposed to a diverse array of microbes, as well as their metabolite byproducts <xref rid="bb0050" ref-type="bibr">[10]</xref>. The gut microbiome influences the development of the immune system of the host, and conversely the immune system regulates the microbe composition in the gut <xref rid="bb0025" ref-type="bibr">[5]</xref>, <xref rid="bb0055" ref-type="bibr">[11]</xref>. Microorganisms in the gut play a key role in the activation, training and regulation of the host immune system <xref rid="bb0060" ref-type="bibr">[12]</xref>. The communication between the intestinal microflora and the host's immune system begins at a very early stage of development <xref rid="bb0065" ref-type="bibr">[13]</xref>. Intestinal microbes can recruit immune cells and initiate inflammatory reactions, which play a direct role in promoting the maturation of the immune system <xref rid="bb0050" ref-type="bibr">[10]</xref>, <xref rid="bb0070" ref-type="bibr">[14]</xref>. The intestinal mucosal immune system is a protective barrier system composed of cellular (i.e. epithelial- and mesoderm-derived immune cells) and non-cellular components (e.g. antimicrobial peptides, cytokines and antibodies), which can resist microbial attack <xref rid="bb0075" ref-type="bibr">[15]</xref>.</p><p id="p0025">On the one hand, intestinal microbes affect the host immune system through secretion of metabolites (e.g. butyrate, L-tryptophan, indole, bile acids and retinoic acid), signaling pathways (e.g. Toll-like receptors and Nod-like receptors), and small noncoding RNAs (e.g. miRNA) <xref rid="bb0045" ref-type="bibr">[9]</xref>, <xref rid="bb0080" ref-type="bibr">[16]</xref>. On the other hand, the intestinal immune system exposes bacteria to the host, reducing pathological outcomes, and modulating the stratification of bacteria in the epithelial barrier <xref rid="bb0085" ref-type="bibr">[17]</xref>. The intestinal immune system affects the composition of bacteria, whereas the bacteria promote the development of the intestinal immune system. Disruption of the relationship between intestinal bacteria and the host immune system will affect the overall health of the host <xref rid="bb0075" ref-type="bibr">[15]</xref>, <xref rid="bb0085" ref-type="bibr">[17]</xref>. Intestinal epithelial cells recognize pathogen-associated molecular structures (such as lipopolysaccharides and flagella) through their surface Toll-like receptors. This triggers the maturation of antigen-presenting cells (such as dendritic cells), the initiation of immune responses, and the release of inflammatory factors, which are associated with the development of CRC <xref rid="bb0090" ref-type="bibr">[18]</xref>. This dysregulation of the host immune system represents a potential mechanism for the effect of intestinal microbes on the development and progression of CRC <xref rid="bb0095" ref-type="bibr">[19]</xref>.</p></sec><sec id="s0015"><title>Invasion of <italic toggle="yes">Fusobacterium nucleatum</italic> Contributes to the Carcinogenesis of CRC</title><p id="p0030"><italic toggle="yes">Fusobacterium nucleatum</italic> (<italic toggle="yes">F. nucleatum</italic>) is a Gram-negative, anaerobic oral commensal bacterium that is associated with a variety of human diseases, including periodontal disease <xref rid="bb0100" ref-type="bibr">[20]</xref>, Alzheimer's disease <xref rid="bb0105" ref-type="bibr">[21]</xref>, brain abscess <xref rid="bb0110" ref-type="bibr">[22]</xref>, cardiovascular disease <xref rid="bb0115" ref-type="bibr">[23]</xref>, miscarriage <xref rid="bb0120" ref-type="bibr">[24]</xref> and inflammatory bowel disease <xref rid="bb0125" ref-type="bibr">[25]</xref>. Recently, <italic toggle="yes">F. nucleatum</italic> has been proposed to be associated with CRC <xref rid="bb0130" ref-type="bibr">[26]</xref>. <italic toggle="yes">F. nucleatum</italic> promotes the occurrence of CRC through several virulence mechanisms: colonization, invasion, and modulation of host immune response <xref rid="bb0135" ref-type="bibr">[27]</xref>.</p><p id="p0035"><italic toggle="yes">F. nucleatum</italic> bacteria interact with each other by expressing a variety of different virulence factors, and can adhere to many different mammalian cell types, including epithelial and endothelial cells, polymorph nuclear neutrophils, monocytes, erythrocytes, fibroblasts, and natural killer (NK) cells <xref rid="bb0140" ref-type="bibr">[28]</xref>, <xref rid="bb0145" ref-type="bibr">[29]</xref>. The cell surface protein FadA is a key virulence factor in <italic toggle="yes">F. nucleatum</italic> which regulates adhesion and invasion of the bacterium. The expression of FadA gene in human CRC specimens was significantly higher than that in adjacent normal tissues <xref rid="bb0150" ref-type="bibr">[30]</xref>. This protein enables <italic toggle="yes">F. nucleatum</italic> to bind E-cadherin in CRC and epithelial cells, activate the &#946;-catenin pathway, and induce the expression of transcription factors lymphoid enhancer factor (LEF)/T cell factor (TCF) which promote tumor cell growth <xref rid="bb0150" ref-type="bibr">[30]</xref>, <xref rid="bb0155" ref-type="bibr">[31]</xref>. It's recently reported that FadA can up-regulate Wnt/&#946;-catenin modulator Annexin A1 expression through E-cadherin <xref rid="bb0160" ref-type="bibr">[32]</xref>. FadA can also bind to endothelial cells VE-cadherin, which is a linker molecule on endothelial cells <xref rid="bb0165" ref-type="bibr">[33]</xref>. This combination alters the integrity of the endothelium, increases the permeability of the endothelium, and allows the bacteria to overcome the blood brain barriers, placental barriers, and colonize different parts of the body <xref rid="bb0170" ref-type="bibr">[34]</xref>. Outer membrane vesicles (OMVs) from <italic toggle="yes">F. nucleatum</italic> can degrade E-cadherin, thus promoting bacterial invasion and tumor metastasis <xref rid="bb0175" ref-type="bibr">[35]</xref>.</p><p id="p0040">In addition, <italic toggle="yes">F. nucleatum</italic> also has two other outer membrane proteins, Fap2 and RadD <xref rid="bb0180" ref-type="bibr">[36]</xref>. The lectin Fap2 can bind Gal-GalNAc, a polysaccharide overexpressed in CRC. This binding of Fap2 facilitates colonization of <italic toggle="yes">F. nucleatum</italic> and explicates fusobacteria abundance in CRC <xref rid="bb0185" ref-type="bibr">[37]</xref>. RadD can mediate communication between <italic toggle="yes">F. nucleatum</italic> and other bacterial species, contributing to the formation of multispecies biofilms <xref rid="bb0180" ref-type="bibr">[36]</xref>, <xref rid="bb0190" ref-type="bibr">[38]</xref>, which has been shown to be associated with proximal colon cancer <xref rid="bb0195" ref-type="bibr">[39]</xref>.</p></sec><sec id="s0020"><title><italic toggle="yes">F. nucleatum</italic>-Induced Inflammation Contributes to CRC Development</title><p id="p0045">There has been a growing body of literature suggesting a link between chronic inflammation and CRC, in which gastrointestinal inflammation may promote CRC development <xref rid="bb0150" ref-type="bibr">[30]</xref>. Increased evidence suggests that <italic toggle="yes">F. nucleatum</italic> can shape the inflammatory microenvironment in the CRC, promoting tumor growth and metastasis <xref rid="bb0200" ref-type="bibr">[40]</xref>. For example, <italic toggle="yes">F</italic>. <italic toggle="yes">nucleatum</italic> can stimulate reactive oxygen species (ROS) production, inducing inflammatory responses in CRC cells <xref rid="bb0205" ref-type="bibr">[41]</xref>. Infection of CRC cells with <italic toggle="yes">F. nucleatum</italic> increased the expression of miR21, a pathogenic role in chronic inflammation and colitis-associated colon cancer, therefore promoting tumor cell proliferation and invasive activity <xref rid="bb0040" ref-type="bibr">[8]</xref>, <xref rid="bb0210" ref-type="bibr">[42]</xref>.</p><p id="p0050">Adherence of <italic toggle="yes">F. nucleatum</italic> to CRC cells via FadA stimulates the release of inflammatory factors, such as NF-&#954;B, IL-6, IL-8, IL-10 and IL-18, which promote cell proliferation in CRC <xref rid="bb0150" ref-type="bibr">[30]</xref>. In patients with <italic toggle="yes">F. nucleatum</italic> infection, strong humoral immunity is induced, and antibodies against <italic toggle="yes">F. nucleatum</italic>, IgA and IgG are present <xref rid="bb0215" ref-type="bibr">[43]</xref>. <italic toggle="yes">F. nucleatum</italic> infection increases the infiltration of inflammatory cells, such as macrophages, dendritic cells, and granulocytes, which create a pro-inflammatory microenvironment that is conducive to the occurrence of CRC <xref rid="bb0220" ref-type="bibr">[44]</xref>. Macrophages infected with <italic toggle="yes">F. nucleatum</italic> can induce the release of inflammatory cytokines <xref rid="bb0225" ref-type="bibr">[45]</xref>, <xref rid="bb0230" ref-type="bibr">[46]</xref>. Natural cytotoxic receptor NKp46 of NK cell can directly recognize <italic toggle="yes">F. nucleatum</italic> through its surface ligand, secreting TNF-&#945; to aggravate inflammation <xref rid="bb0100" ref-type="bibr">[20]</xref>. Some inflammatory response signatures were specific to <italic toggle="yes">F. nucleatum</italic> but not to other bacteria founded in CRC tissues, such as IL1&#946;, IL24, PTGS2 (COX-2), IL8, IL6 and TNF, which were enriched in <italic toggle="yes">F. nucleatum-</italic>infected CRCs <xref rid="bb0220" ref-type="bibr">[44]</xref>.</p><p id="p0055"><italic toggle="yes">F. nucleatum</italic> is prevalent in gastrointestinal inflammation diseases especially inflammatory bowel disease (IBD) <xref rid="bb0125" ref-type="bibr">[25]</xref>. <italic toggle="yes">F. nucleatum</italic> strains originating from IBD patients were significantly more invasive than strains isolated from healthy tissues <xref rid="bb0125" ref-type="bibr">[25]</xref>. Highly invasive <italic toggle="yes">F. nucleatum</italic> isolates derived from the inflamed area of human Crohn's disease triggered high expression of MUC2 and TNF-&#945; in colon cancer cells <xref rid="bb0235" ref-type="bibr">[47]</xref>. In IBD patients, the release of IL-1&#946; and TNF-&#945; can damage colon cells and impair epithelial integrity, which increases the chance of contact between <italic toggle="yes">F. nucleatum</italic> and the colon epithelium <xref rid="bb0240" ref-type="bibr">[48]</xref>. This may partially explain why patients with IBD are susceptible to CRC. Mechanisms of adhesion, invasion and inflammation mediated by <italic toggle="yes">F. nucleatum</italic> in CRCs were summarized in <xref rid="t0005" ref-type="table">Table 1</xref>.<table-wrap position="float" id="t0005" orientation="portrait"><label>Table 1</label><caption><p><italic toggle="yes">Fusobacterium nucleatum</italic> induced invasion and inflammation contributes to colorectal cancer</p></caption><alt-text id="al0015">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Virulence factor</th><th colspan="1" rowspan="1">Function</th><th colspan="1" rowspan="1">Mechanisms</th><th colspan="1" rowspan="1">References</th></tr></thead><tbody><tr><td rowspan="3" colspan="1">Fn infection</td><td colspan="1" rowspan="1">Pro-inflammatory microenvironment</td><td colspan="1" rowspan="1">Inducing inflammatory cells infiltration</td><td colspan="1" rowspan="1"><xref rid="bb0245" ref-type="bibr">[49]</xref></td></tr><tr><td colspan="1" rowspan="1">Inflammatory cytokines production</td><td colspan="1" rowspan="1">Accumulation of reactive oxygen species</td><td colspan="1" rowspan="1"><xref rid="bb0205" ref-type="bibr">[41]</xref></td></tr><tr><td colspan="1" rowspan="1">Cell proliferation and invasion</td><td colspan="1" rowspan="1">Increasing the expression of miR21</td><td colspan="1" rowspan="1"><xref rid="bb0040" ref-type="bibr">[8]</xref>, <xref rid="bb0210" ref-type="bibr">[42]</xref></td></tr><tr><td rowspan="3" colspan="1">FadA</td><td rowspan="2" colspan="1">Cell proliferation</td><td colspan="1" rowspan="1">Activating the &#946;-catenin pathway</td><td colspan="1" rowspan="1"><xref rid="bb0150" ref-type="bibr">[30]</xref>, <xref rid="bb0155" ref-type="bibr">[31]</xref></td></tr><tr><td colspan="1" rowspan="1">Up-regulating Wnt/&#946;-catenin modulator Annexin A1</td><td colspan="1" rowspan="1"><xref rid="bb0160" ref-type="bibr">[32]</xref></td></tr><tr><td colspan="1" rowspan="1">Bacterial colonization</td><td colspan="1" rowspan="1">Binding endothelial cell VE-cadherin</td><td colspan="1" rowspan="1"><xref rid="bb0165" ref-type="bibr">[33]</xref>, <xref rid="bb0170" ref-type="bibr">[34]</xref></td></tr><tr><td colspan="1" rowspan="1">Fap2</td><td colspan="1" rowspan="1">Bacterial colonization</td><td colspan="1" rowspan="1">Binding Gal-GalNAc overexpressed in CRC</td><td colspan="1" rowspan="1"><xref rid="bb0185" ref-type="bibr">[37]</xref></td></tr><tr><td colspan="1" rowspan="1">RadD</td><td colspan="1" rowspan="1">Biofilms formation</td><td colspan="1" rowspan="1">Mediating communication between Fn and other bacteria</td><td colspan="1" rowspan="1"><xref rid="bb0180" ref-type="bibr">[36]</xref>, <xref rid="bb0190" ref-type="bibr">[38]</xref></td></tr><tr><td colspan="1" rowspan="1">LPS</td><td colspan="1" rowspan="1">Inflammatory cytokines production</td><td colspan="1" rowspan="1">Activating immune cells</td><td colspan="1" rowspan="1"><xref rid="bb0275" ref-type="bibr">[55]</xref></td></tr><tr><td colspan="1" rowspan="1">OMVs</td><td colspan="1" rowspan="1">Bacterial invasion and tumor metastasis</td><td colspan="1" rowspan="1">Degrading E-cadherin</td><td colspan="1" rowspan="1"><xref rid="bb0175" ref-type="bibr">[35]</xref></td></tr></tbody></table><table-wrap-foot><fn><p>Fn, <italic toggle="yes">Fusobacterium nucleatum</italic>; CRC, colorectal cancer; OMV, outer membrane vesicles.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="s0025"><title><italic toggle="yes">F. nucleatum</italic>-Induced Immune Suppression Promotes CRC Development</title><sec id="s0030"><title>Macrophages</title><p id="p0060"><italic toggle="yes">F. nucleatum</italic> modulates the tumor immune environment by amplifying bone marrow-derived cells <xref rid="bb0245" ref-type="bibr">[49]</xref> such as tumor-associated macrophages, which play an important role in tumor invasion and metastasis <xref rid="bb0250" ref-type="bibr">[50]</xref>. Meanwhile, the tumor microenvironment can affect the heterogeneity of macrophages, which can differentiate from pro-inflammatory M1-phenotype to a tumor-promoting M2-phenotype <xref rid="bb0255" ref-type="bibr">[51]</xref>, <xref rid="bb0260" ref-type="bibr">[52]</xref>.</p><p id="p0065">Our recent study revealed that <italic toggle="yes">F. nucleatum</italic> displayed an immunosuppressive effect by promoting M2 polarization of macrophages in <italic toggle="yes">F. nucleatum</italic>-related CRCs, possibly through the TLR4/IL-6/p-STAT3/c-MYC signaling pathway <xref rid="bb0265" ref-type="bibr">[53]</xref>. <italic toggle="yes">F. nucleatum</italic> induces infiltration of M2 macrophages in the colorectal environment, thus forming a tumor-promoting microenvironment <xref rid="bb0270" ref-type="bibr">[54]</xref>, <xref rid="bb0275" ref-type="bibr">[55]</xref>. The metabolite of <italic toggle="yes">F. nucleatum</italic>, butyric acid, can induce apoptosis in monocytes/macrophages and lymphocytes by activating free fatty acid receptors <xref rid="bb0280" ref-type="bibr">[56]</xref>. In addition, <italic toggle="yes">F. nucleatum</italic> can invade macrophages and induce the expression of indoleamine2,3-dioxygenase on the cell surface, creating a toxic microenvironment which impairs the function of peripheral blood lymphocytes, thereby allowing macrophages to escape cytotoxic T lymphocyte attack <xref rid="bb0275" ref-type="bibr">[55]</xref>.</p></sec><sec id="s0035"><title>T cells</title><p id="p0070">T cell activity can be inhibited by the virulence factors of <italic toggle="yes">F. nucleatum</italic>
<xref rid="bb0180" ref-type="bibr">[36]</xref>, <xref rid="bb0285" ref-type="bibr">[57]</xref>. <italic toggle="yes">F. nucleatum</italic> abundance is negatively correlated with CD3<sup>+</sup>T cell density in CRC <xref rid="bb0005" ref-type="bibr">[1]</xref>. Additionally, we have shown that a high abundance of <italic toggle="yes">F. nucleatum</italic> in CRC is associated with lower numbers of CD4<sup>+</sup>T cells <xref rid="bb0290" ref-type="bibr">[58]</xref>. Decreased T cell density in CRC could be explained by apoptotic cell death and arrested proliferation of T cells induced by <italic toggle="yes">F. nucleatum</italic>
<xref rid="bb0295" ref-type="bibr">[59]</xref>, <xref rid="bb0300" ref-type="bibr">[60]</xref>, <xref rid="bb0305" ref-type="bibr">[61]</xref>. For example, <italic toggle="yes">F. nucleatum</italic> inhibitory protein (FIP) can inhibit human T cell activation by arresting cells in the G1 phase of the cell cycle <xref rid="bb0300" ref-type="bibr">[60]</xref>. A recent study revealed that the association of <italic toggle="yes">F. nucleatum</italic> with tumor-infiltrating lymphocytes (TIL) differed by MSI status of CRC. The presence of <italic toggle="yes">F. nucleatum</italic> was negatively associated with TIL in MSI-high tumors, but positively in non-MSI-high tumors <xref rid="bb0310" ref-type="bibr">[62]</xref>.</p><p id="p0075">In the colorectal tumor microenvironment, <italic toggle="yes">F. nucleatum</italic> can release short-peptides (formylmethionyl-leucyl-phenylalanine) and short-chain fatty acids (butyrate, propionate, and acetate) which lead to recruitment of myeloid-derived suppressor cells (MDSCs) <xref rid="bb0240" ref-type="bibr">[48]</xref>. MDSCs can regulate immune response by suppressing CD4<sup>+</sup> T helper cell function, inhibiting T cell proliferation, and inducing T cell apoptosis <xref rid="bb0240" ref-type="bibr">[48]</xref>, <xref rid="bb0315" ref-type="bibr">[63]</xref>. <italic toggle="yes">F. nucleatum</italic> can also induce human lymphocyte death through Fap2 and RadD <xref rid="bb0180" ref-type="bibr">[36]</xref>. Fap2 of <italic toggle="yes">F. nucleatum</italic> can inhibit human T cell activation by directly interacted with TIGIT, an inhibitory receptor present on various T cells <xref rid="bb0285" ref-type="bibr">[57]</xref>. Moreover, <italic toggle="yes">F. nucleatum</italic> can interact directly with monocytes, which may recruit T helper 17 cells and T regulatory cells through CCL20/CCR6 pathway, promoting CRC formation <xref rid="bb0320" ref-type="bibr">[64]</xref>.</p></sec><sec id="s0040"><title>NK Cells</title><p id="p0080">All human NK cells express the Fap2 receptor TIGIT, which recognizes poliovirus receptor (PVR) and nectin-2 as ligands <xref rid="bb0325" ref-type="bibr">[65]</xref>. This binding of NK cells to <italic toggle="yes">F. nucleatum</italic> inhibits the killing activity of NK cells, thereby promoting the formation of colorectal tumors <xref rid="bb0175" ref-type="bibr">[35]</xref>, <xref rid="bb0285" ref-type="bibr">[57]</xref>, <xref rid="bb0330" ref-type="bibr">[66]</xref>.</p></sec><sec id="s0045"><title>Dendritic Cells</title><p id="p0085">The infiltration of CD103<sup>+</sup> dendritic cells (DCs) was increased in tumors from <italic toggle="yes">F. nucleatum</italic>-fed mice compared with control group <xref rid="bb0220" ref-type="bibr">[44]</xref>. This population of DCs can promote the expansion of Foxp3<sup>+</sup> regulatory T cells, a CD4<sup>+</sup> T cell subset that inhibits cytotoxic and effector T cells, therefore diminishing anti-tumor immunity <xref rid="bb0335" ref-type="bibr">[67]</xref>.</p></sec><sec id="s0050"><title>Tumor-Associated Neutrophils</title><p id="p0090">Amount of tumor-associated neutrophils (TANs) in intestinal tumors of <italic toggle="yes">F. nucleatum</italic>-fed mice was significantly increased compared with controls <xref rid="bb0220" ref-type="bibr">[44]</xref>. It's recently reported that TANs play a role in tumor progression and in the regulation of anti-tumor immunity <xref rid="bb0340" ref-type="bibr">[68]</xref>. Increased TANs in CRC associate with malignant phenotype and predict poor prognosis of patients with CRC <xref rid="bb0345" ref-type="bibr">[69]</xref>. These findings suggest that <italic toggle="yes">F. nucleatum</italic> may suppress antitumor immunity through inducing the infiltration of TANs in CRC.</p><p id="p0095">Representative images of infiltrating immune cells in <italic toggle="yes">F. nucleatum</italic>-related CRC were shown in <xref rid="f0005" ref-type="fig">Figure 1</xref>. Adhesion, invasion, inflammation and immune suppression mediated by <italic toggle="yes">F. nucleatum</italic> in CRC was sketched in <xref rid="f0010" ref-type="fig">Figure 2</xref>. Mechanisms of immune suppression induced by <italic toggle="yes">F. nucleatum</italic> in CRC were summarized in <xref rid="t0010" ref-type="table">Table 2</xref>.<fig id="f0005" position="float" orientation="portrait"><label>Figure 1</label><caption><p><bold>Infiltrating immune cell populations in human <italic toggle="yes">F. nucleatum</italic> related colorectal cancer.</bold> High abundance of <italic toggle="yes">F. nucleatum</italic> within colon cancer tissue (A) and matched metastatic lymph nodes (B) detected by immunofluorescence. High density of immune cells (CD3<sup>+</sup>, CD68<sup>+</sup>, CD83<sup>+</sup>, and NE cells) within the environment of <italic toggle="yes">F. nucleatum</italic>-positive colon cancers (immunofluorescence). NE, neutrophils.</p></caption><alt-text id="al0005">Figure 1</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr1.jpg"/></fig><fig id="f0010" position="float" orientation="portrait"><label>Figure 2</label><caption><p><bold><italic toggle="yes">F. nucleatum</italic> induces a pro-inflammatory microenvironment and suppression of host immunity that favor tumor growth within the gut mucosa</bold>. <italic toggle="yes">F. nucleatum</italic> binds to colon epithelium through FadA, Fap2 and RadD, and invades the mucosa. This invasion by <italic toggle="yes">F. nucleatum</italic> increases the infiltration of inflammatory cells and the release of cytokines which stimulate cell proliferation. Moreover, invasive <italic toggle="yes">F. nucleatum</italic> interacts with the immune cells in the colon mucosa, resulting in the decrease of T cell density, increased M2 macrophage polarization, inhibition of NK cell activity, and the increase of dendritic cells and tumor-associated neutrophils that diminish anti-tumor immunity. The inhibition of mucosa immunity favors tumor progression.</p></caption><alt-text id="al0010">Figure 2</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr2.jpg"/></fig><table-wrap position="float" id="t0010" orientation="portrait"><label>Table 2</label><caption><p><italic toggle="yes">Fusobacterium nucleatum</italic> induces immune suppression in colorectal cancer</p></caption><alt-text id="al0020">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Immune cells</th><th colspan="1" rowspan="1">Function</th><th colspan="1" rowspan="1">Mechanism</th><th colspan="1" rowspan="1">References</th></tr></thead><tbody><tr><td rowspan="3" colspan="1">Macrophages</td><td colspan="1" rowspan="1">M2 polarization</td><td colspan="1" rowspan="1">Activating TLR4 signaling pathway</td><td colspan="1" rowspan="1"><xref rid="bb0265" ref-type="bibr">[53]</xref></td></tr><tr><td colspan="1" rowspan="1">Apoptosis</td><td colspan="1" rowspan="1">Butyric acid activating free fatty acid receptors</td><td colspan="1" rowspan="1"><xref rid="bb0280" ref-type="bibr">[56]</xref></td></tr><tr><td colspan="1" rowspan="1">Escape T lymphocyte attack</td><td colspan="1" rowspan="1">Impairing the function of peripheral blood lymphocytes</td><td colspan="1" rowspan="1"><xref rid="bb0275" ref-type="bibr">[55]</xref></td></tr><tr><td rowspan="6" colspan="1">Lymphocytes</td><td colspan="1" rowspan="1">Reducing CD3 + T cells</td><td colspan="1" rowspan="1">Unknown</td><td colspan="1" rowspan="1"><xref rid="bb0005" ref-type="bibr">[1]</xref></td></tr><tr><td colspan="1" rowspan="1">Reducing CD4 + T cells</td><td colspan="1" rowspan="1">Correlated with TOX expression</td><td colspan="1" rowspan="1"><xref rid="bb0290" ref-type="bibr">[58]</xref></td></tr><tr><td colspan="1" rowspan="1">Inhibiting proliferation</td><td colspan="1" rowspan="1">Arresting cells in the G1 phase</td><td colspan="1" rowspan="1"><xref rid="bb0300" ref-type="bibr">[60]</xref></td></tr><tr><td colspan="1" rowspan="1">Inhibiting activation</td><td colspan="1" rowspan="1">Interaction with TIGIT</td><td colspan="1" rowspan="1"><xref rid="bb0285" ref-type="bibr">[57]</xref></td></tr><tr><td rowspan="2" colspan="1">Apoptosis</td><td colspan="1" rowspan="1">Recruitment of MDSCs</td><td colspan="1" rowspan="1"><xref rid="bb0240" ref-type="bibr">[48]</xref>, <xref rid="bb0315" ref-type="bibr">[63]</xref></td></tr><tr><td colspan="1" rowspan="1">Butyric acid</td><td colspan="1" rowspan="1"><xref rid="bb0280" ref-type="bibr">[56]</xref></td></tr><tr><td colspan="1" rowspan="1">NK cells</td><td colspan="1" rowspan="1">Inhibition of NK cell cytotoxicity</td><td colspan="1" rowspan="1">Fap2 binding TIGIT molecule</td><td colspan="1" rowspan="1"><xref rid="bb0175" ref-type="bibr">[35]</xref>, <xref rid="bb0285" ref-type="bibr">[57]</xref></td></tr><tr><td colspan="1" rowspan="1">DCs</td><td colspan="1" rowspan="1">Dampening anti-tumor immunity</td><td colspan="1" rowspan="1">Promoting the expansion of regulatory T cells</td><td colspan="1" rowspan="1"><xref rid="bb0335" ref-type="bibr">[67]</xref></td></tr><tr><td colspan="1" rowspan="1">TANs</td><td colspan="1" rowspan="1">Dampening anti-tumor immunity</td><td colspan="1" rowspan="1">Increasing the number of TANs</td><td colspan="1" rowspan="1"><xref rid="bb0220" ref-type="bibr">[44]</xref></td></tr></tbody></table><table-wrap-foot><fn><p>TOX, thymocyte selection-associated high-mobility group box; MDSCs, myeloid-derived suppressor cells; NK, natural killer; DCs, dendritic cells; TANs, tumor-associated neutrophils.</p></fn></table-wrap-foot></table-wrap></p></sec></sec><sec id="s0055"><title>Conclusion</title><p id="p0100">The presence of <italic toggle="yes">F. nucleatum</italic> as symbiotic bacteria in the human intestinal tract has been confirmed to be related to the development of CRC. <italic toggle="yes">F. nucleatum</italic> promotes CRC through different virulence mechanisms, such as adhesion to the intestinal epithelium and inducing inflammatory and immune responses in the host. The resistance reactions induced in the host by <italic toggle="yes">F. nucleatum</italic> induce an inflammatory environment in the host, and promote the recruitment of inflammatory cells as well as the secretion of inflammatory factors. This response to <italic toggle="yes">F. nucleatum</italic> creates a microenvironment which favors tumor growth. Furthermore, <italic toggle="yes">F. nucleatum</italic> can induce immune suppression of gut mucosa by suppressing the function of immune cells such as macrophages, T cells and NK cells, contributing to the progression of CRC.</p></sec><sec id="s0060"><title>Conflicts of Interest</title><p id="p0105">Authors declare no Conflict of Interests for this article.</p></sec><sec id="s0065"><title>Funding</title><p id="p0110">This work was supported by Natural Science Foundation of Sichuan Science and Technology Agency under Award No. 2018JY0167.</p></sec></body><back><ref-list id="bi0005"><title>References</title><ref id="bb0005"><label>1</label><element-citation publication-type="journal" id="rf0005"><person-group person-group-type="author"><name name-style="western"><surname>Mima</surname><given-names>K.</given-names></name><name name-style="western"><surname>Sukawa</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Nishihara</surname><given-names>R.</given-names></name><name name-style="western"><surname>Qian</surname><given-names>Z.R.</given-names></name><name name-style="western"><surname>Yamauchi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Inamura</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Masuda</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nowak</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Nosho</surname><given-names>K.</given-names></name></person-group><article-title><italic toggle="yes">Fusobacterium nucleatum</italic> and T cells in colorectal carcinoma</article-title><source>JAMA Oncol</source><volume>1</volume><issue>5</issue><year>2015</year><fpage>653</fpage><lpage>661</lpage><pub-id pub-id-type="pmid">26181352</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamaoncol.2015.1377</pub-id><pub-id pub-id-type="pmcid">PMC4537376</pub-id></element-citation></ref><ref id="bb0010"><label>2</label><element-citation publication-type="journal" id="rf0010"><person-group person-group-type="author"><name name-style="western"><surname>Sethi</surname><given-names>V.</given-names></name><name name-style="western"><surname>Kurtom</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tarique</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lavania</surname><given-names>S.</given-names></name><name name-style="western"><surname>Malchiodi</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Hellmund</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>U.</given-names></name><name name-style="western"><surname>Giri</surname><given-names>B.</given-names></name><name name-style="western"><surname>Garg</surname><given-names>B.</given-names></name></person-group><article-title>Gut microbiota promotes tumor growth in mice by modulating immune response</article-title><source>Gastroenterology</source><volume>155</volume><issue>1</issue><year>2018</year><fpage>33</fpage><lpage>37.e6</lpage><pub-id pub-id-type="pmid">29630898</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.gastro.2018.04.001</pub-id><pub-id pub-id-type="pmcid">PMC6035070</pub-id></element-citation></ref><ref id="bb0015"><label>3</label><element-citation publication-type="journal" id="rf0015"><person-group person-group-type="author"><name name-style="western"><surname>Louis</surname><given-names>P</given-names></name><name name-style="western"><surname>Hold</surname><given-names>GL</given-names></name><name name-style="western"><surname>Flint</surname><given-names>HJ</given-names></name></person-group><article-title>The gut microbiota, bacterial metabolites and colorectal cancer</article-title><source>Nat Rev Microbiol</source><volume>12</volume><issue>10</issue><year>2014</year><fpage>661</fpage><lpage>672</lpage><pub-id pub-id-type="pmid">25198138</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrmicro3344</pub-id></element-citation></ref><ref id="bb0020"><label>4</label><element-citation publication-type="journal" id="rf0020"><person-group person-group-type="author"><name name-style="western"><surname>Hall</surname><given-names>AB</given-names></name><name name-style="western"><surname>Tolonen</surname><given-names>AC</given-names></name><name name-style="western"><surname>Xavier</surname><given-names>RJ</given-names></name></person-group><article-title>Human genetic variation and the gut microbiome in disease</article-title><source>Nat Rev Genet</source><volume>18</volume><issue>11</issue><year>2017</year><fpage>690</fpage><lpage>699</lpage><pub-id pub-id-type="pmid">28824167</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrg.2017.63</pub-id></element-citation></ref><ref id="bb0025"><label>5</label><element-citation publication-type="journal" id="rf0025"><person-group person-group-type="author"><name name-style="western"><surname>Tilg</surname><given-names>H</given-names></name><name name-style="western"><surname>Adolph</surname><given-names>TE</given-names></name><name name-style="western"><surname>Gerner</surname><given-names>RR</given-names></name><name name-style="western"><surname>Moschen</surname><given-names>AR</given-names></name></person-group><article-title>The intestinal microbiota in colorectal cancer</article-title><source>Cancer Cell</source><volume>33</volume><issue>6</issue><year>2018</year><fpage>954</fpage><lpage>964</lpage><pub-id pub-id-type="pmid">29657127</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ccell.2018.03.004</pub-id></element-citation></ref><ref id="bb0030"><label>6</label><element-citation publication-type="journal" id="rf0030"><person-group person-group-type="author"><name name-style="western"><surname>Flemer</surname><given-names>B.</given-names></name><name name-style="western"><surname>Lynch</surname><given-names>D.B.</given-names></name><name name-style="western"><surname>Brown</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Jeffery</surname><given-names>I.B.</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>F.J.</given-names></name><name name-style="western"><surname>Claesson</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>O'Riordain</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shanahan</surname><given-names>F.</given-names></name><name name-style="western"><surname>O'Toole</surname><given-names>P.W.</given-names></name></person-group><article-title>Tumour-associated and non-tumour-associated microbiota in colorectal cancer</article-title><source>Gut</source><volume>66</volume><issue>4</issue><year>2017</year><fpage>633</fpage><lpage>643</lpage><pub-id pub-id-type="pmid">26992426</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gutjnl-2015-309595</pub-id><pub-id pub-id-type="pmcid">PMC5529966</pub-id></element-citation></ref><ref id="bb0035"><label>7</label><element-citation publication-type="journal" id="rf0035"><person-group person-group-type="author"><name name-style="western"><surname>Eklof</surname><given-names>V.</given-names></name><name name-style="western"><surname>Lofgren-Burstrom</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zingmark</surname><given-names>C.</given-names></name><name name-style="western"><surname>Edin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Larsson</surname><given-names>P.</given-names></name><name name-style="western"><surname>Karling</surname><given-names>P.</given-names></name><name name-style="western"><surname>Alexeyev</surname><given-names>O.</given-names></name><name name-style="western"><surname>Rutegard</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wikberg</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Palmqvist</surname><given-names>R.</given-names></name></person-group><article-title>Cancer-associated fecal microbial markers in colorectal cancer detection</article-title><source>Int J Cancer</source><volume>141</volume><issue>12</issue><year>2017</year><fpage>2528</fpage><lpage>2536</lpage><pub-id pub-id-type="pmid">28833079</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ijc.31011</pub-id><pub-id pub-id-type="pmcid">PMC5697688</pub-id></element-citation></ref><ref id="bb0040"><label>8</label><element-citation publication-type="journal" id="rf0040"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Weng</surname><given-names>W.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hong</surname><given-names>L.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Toiyama</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>R.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>C.</given-names></name></person-group><article-title><italic toggle="yes">Fusobacterium nucleatum</italic> increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signaling to nuclear factor-kappaB, and up-regulating expression of microRNA-21</article-title><source>Gastroenterology</source><volume>152</volume><issue>4</issue><year>2017</year><fpage>851</fpage><lpage>866.e24</lpage><pub-id pub-id-type="pmid">27876571</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.gastro.2016.11.018</pub-id><pub-id pub-id-type="pmcid">PMC5555435</pub-id></element-citation></ref><ref id="bb0045"><label>9</label><element-citation publication-type="journal" id="rf0045"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Huycke</surname><given-names>MM</given-names></name></person-group><article-title>Microbiome-driven carcinogenesis in colorectal cancer: models and mechanisms</article-title><source>Free Radic Biol Med</source><volume>105</volume><year>2017</year><fpage>3</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">27810411</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.freeradbiomed.2016.10.504</pub-id></element-citation></ref><ref id="bb0050"><label>10</label><element-citation publication-type="journal" id="rf0050"><person-group person-group-type="author"><name name-style="western"><surname>Kurilshikov</surname><given-names>A</given-names></name><name name-style="western"><surname>Wijmenga</surname><given-names>C</given-names></name><name name-style="western"><surname>Fu</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhernakova</surname><given-names>A</given-names></name></person-group><article-title>Host genetics and gut microbiome: challenges and perspectives</article-title><source>Trends Immunol</source><volume>38</volume><issue>9</issue><year>2017</year><fpage>633</fpage><lpage>647</lpage><pub-id pub-id-type="pmid">28669638</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.it.2017.06.003</pub-id></element-citation></ref><ref id="bb0055"><label>11</label><element-citation publication-type="journal" id="rf0055"><person-group person-group-type="author"><name name-style="western"><surname>Zeng</surname><given-names>MY</given-names></name><name name-style="western"><surname>Inohara</surname><given-names>N</given-names></name><name name-style="western"><surname>Nunez</surname><given-names>G</given-names></name></person-group><article-title>Mechanisms of inflammation-driven bacterial dysbiosis in the gut</article-title><source>Mucosal Immunol</source><volume>10</volume><issue>1</issue><year>2017</year><fpage>18</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">27554295</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/mi.2016.75</pub-id><pub-id pub-id-type="pmcid">PMC5788567</pub-id></element-citation></ref><ref id="bb0060"><label>12</label><element-citation publication-type="journal" id="rf0060"><person-group person-group-type="author"><name name-style="western"><surname>Belkaid</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hand</surname><given-names>TW</given-names></name></person-group><article-title>Role of the microbiota in immunity and inflammation</article-title><source>Cell</source><volume>157</volume><issue>1</issue><year>2014</year><fpage>121</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">24679531</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2014.03.011</pub-id><pub-id pub-id-type="pmcid">PMC4056765</pub-id></element-citation></ref><ref id="bb0065"><label>13</label><element-citation publication-type="journal" id="rf0065"><person-group person-group-type="author"><name name-style="western"><surname>Falony</surname><given-names>G.</given-names></name><name name-style="western"><surname>Joossens</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vieira-Silva</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Darzi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Faust</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kurilshikov</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bonder</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Valles-Colomer</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vandeputte</surname><given-names>D.</given-names></name></person-group><article-title>Population-level analysis of gut microbiome variation</article-title><source>Science</source><volume>352</volume><issue>6285</issue><year>2016</year><fpage>560</fpage><lpage>564</lpage><pub-id pub-id-type="pmid">27126039</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.aad3503</pub-id></element-citation></ref><ref id="bb0070"><label>14</label><element-citation publication-type="journal" id="rf0070"><person-group person-group-type="author"><name name-style="western"><surname>Ost</surname><given-names>KS</given-names></name><name name-style="western"><surname>Round</surname><given-names>JL</given-names></name></person-group><article-title>A few good commensals: gut microbes use ifn-gamma to fight salmonella</article-title><source>Immunity</source><volume>46</volume><issue>6</issue><year>2017</year><fpage>977</fpage><lpage>979</lpage><pub-id pub-id-type="pmid">28636967</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2017.06.010</pub-id></element-citation></ref><ref id="bb0075"><label>15</label><element-citation publication-type="journal" id="rf0075"><person-group person-group-type="author"><name name-style="western"><surname>Sina</surname><given-names>C</given-names></name><name name-style="western"><surname>Kemper</surname><given-names>C</given-names></name><name name-style="western"><surname>Derer</surname><given-names>S</given-names></name></person-group><article-title>The intestinal complement system in inflammatory bowel disease: Shaping intestinal barrier function</article-title><source>Semin Immunol</source><volume>37</volume><year>2018</year><fpage>66</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">29486961</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.smim.2018.02.008</pub-id></element-citation></ref><ref id="bb0080"><label>16</label><element-citation publication-type="journal" id="rf0080"><person-group person-group-type="author"><name name-style="western"><surname>Postler</surname><given-names>TS</given-names></name><name name-style="western"><surname>Ghosh</surname><given-names>S</given-names></name></person-group><article-title>Understanding the holobiont: how microbial metabolites affect human health and shape the immune system</article-title><source>Cell Metab</source><volume>26</volume><issue>1</issue><year>2017</year><fpage>110</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">28625867</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2017.05.008</pub-id><pub-id pub-id-type="pmcid">PMC5535818</pub-id></element-citation></ref><ref id="bb0085"><label>17</label><element-citation publication-type="journal" id="rf0085"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>K.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>G.</given-names></name><name name-style="western"><surname>Bai</surname><given-names>M.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>C.</given-names></name><name name-style="western"><surname>Li</surname><given-names>T.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>Y.</given-names></name></person-group><article-title>Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism</article-title><source>Front Cell Infect Microbiol</source><volume>8</volume><year>2018</year><fpage>13</fpage><pub-id pub-id-type="pmid">29468141</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcimb.2018.00013</pub-id><pub-id pub-id-type="pmcid">PMC5808205</pub-id></element-citation></ref><ref id="bb0090"><label>18</label><element-citation publication-type="journal" id="rf0090"><person-group person-group-type="author"><name name-style="western"><surname>Cremonesi</surname><given-names>E.</given-names></name><name name-style="western"><surname>Governa</surname><given-names>V.</given-names></name><name name-style="western"><surname>Garzon</surname><given-names>J.F.G.</given-names></name><name name-style="western"><surname>Mele</surname><given-names>V.</given-names></name><name name-style="western"><surname>Amicarella</surname><given-names>F.</given-names></name><name name-style="western"><surname>Muraro</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Trella</surname><given-names>E.</given-names></name><name name-style="western"><surname>Galati-Fournier</surname><given-names>V.</given-names></name><name name-style="western"><surname>Oertli</surname><given-names>D.</given-names></name><name name-style="western"><surname>Daster</surname><given-names>S.R.</given-names></name></person-group><article-title>Gut microbiota modulate T cell trafficking into human colorectal cancer</article-title><source>Gut</source><volume>67</volume><issue>11</issue><year>2018</year><fpage>1984</fpage><lpage>1994</lpage><pub-id pub-id-type="pmid">29437871</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gutjnl-2016-313498</pub-id></element-citation></ref><ref id="bb0095"><label>19</label><element-citation publication-type="journal" id="rf0095"><person-group person-group-type="author"><name name-style="western"><surname>De Arcangelis</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hamade</surname><given-names>H.</given-names></name><name name-style="western"><surname>Alpy</surname><given-names>F.</given-names></name><name name-style="western"><surname>Normand</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bruyere</surname><given-names>E.</given-names></name><name name-style="western"><surname>Lefebvre</surname><given-names>O.</given-names></name><name name-style="western"><surname>Mechine-Neuville</surname><given-names>A.</given-names></name><name name-style="western"><surname>Siebert</surname><given-names>S.</given-names></name><name name-style="western"><surname>Pfister</surname><given-names>V.</given-names></name><name name-style="western"><surname>Lepage</surname><given-names>P.</given-names></name></person-group><article-title>Hemidesmosome integrity protects the colon against colitis and colorectal cancer</article-title><source>Gut</source><volume>66</volume><issue>10</issue><year>2017</year><fpage>1748</fpage><lpage>1760</lpage><pub-id pub-id-type="pmid">27371534</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gutjnl-2015-310847</pub-id><pub-id pub-id-type="pmcid">PMC5595104</pub-id></element-citation></ref><ref id="bb0100"><label>20</label><element-citation publication-type="journal" id="rf0100"><person-group person-group-type="author"><name name-style="western"><surname>Chaushu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wilensky</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gur</surname><given-names>C.</given-names></name><name name-style="western"><surname>Shapira</surname><given-names>L.</given-names></name><name name-style="western"><surname>Elboim</surname><given-names>M.</given-names></name><name name-style="western"><surname>Halftek</surname><given-names>G.</given-names></name><name name-style="western"><surname>Polak</surname><given-names>D.</given-names></name><name name-style="western"><surname>Achdout</surname><given-names>H.</given-names></name><name name-style="western"><surname>Bachrach</surname><given-names>G.</given-names></name><name name-style="western"><surname>Mandelboim</surname><given-names>O.</given-names></name></person-group><article-title>Direct recognition of <italic toggle="yes">Fusobacterium nucleatum</italic> by the NK cell natural cytotoxicity receptor NKp46 aggravates periodontal disease</article-title><source>PLoS Pathog</source><volume>8</volume><issue>3</issue><year>2012</year><object-id pub-id-type="publisher-id">e1002601</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.ppat.1002601</pub-id><pub-id pub-id-type="pmcid">PMC3310798</pub-id><pub-id pub-id-type="pmid">22457623</pub-id></element-citation></ref><ref id="bb0105"><label>21</label><element-citation publication-type="journal" id="rf0105"><person-group person-group-type="author"><name name-style="western"><surname>Sparks Stein</surname><given-names>P.</given-names></name><name name-style="western"><surname>Steffen</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>C.</given-names></name><name name-style="western"><surname>Jicha</surname><given-names>G.</given-names></name><name name-style="western"><surname>Ebersole</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Abner</surname><given-names>E.</given-names></name><name name-style="western"><surname>Dawson</surname><given-names>D.</given-names></name></person-group><article-title>Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease</article-title><source>Alzheimers Dement</source><volume>8</volume><issue>3</issue><year>2012</year><fpage>196</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">22546352</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jalz.2011.04.006</pub-id><pub-id pub-id-type="pmcid">PMC3712346</pub-id></element-citation></ref><ref id="bb0110"><label>22</label><element-citation publication-type="journal" id="rf0110"><person-group person-group-type="author"><name name-style="western"><surname>Kai</surname><given-names>A</given-names></name><name name-style="western"><surname>Cooke</surname><given-names>F</given-names></name><name name-style="western"><surname>Antoun</surname><given-names>N</given-names></name><name name-style="western"><surname>Siddharthan</surname><given-names>C</given-names></name><name name-style="western"><surname>Sule</surname><given-names>O</given-names></name></person-group><article-title>A rare presentation of ventriculitis and brain abscess caused by <italic toggle="yes">Fusobacterium nucleatum</italic></article-title><source>J Med Microbiol</source><volume>57</volume><year>2008</year><fpage>668</fpage><lpage>671</lpage><comment>Pt 5</comment><pub-id pub-id-type="pmid">18436604</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1099/jmm.0.47710-0</pub-id></element-citation></ref><ref id="bb0115"><label>23</label><element-citation publication-type="journal" id="rf0115"><person-group person-group-type="author"><name name-style="western"><surname>Genco</surname><given-names>R</given-names></name><name name-style="western"><surname>Offenbacher</surname><given-names>S</given-names></name><name name-style="western"><surname>Beck</surname><given-names>J</given-names></name></person-group><article-title>Periodontal disease and cardiovascular disease: epidemiology and possible mechanisms</article-title><source>J Am Dent Assoc</source><issue>133 Suppl</issue><year>2002</year><fpage>14S</fpage><lpage>22S</lpage><pub-id pub-id-type="pmid">12085720</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.14219/jada.archive.2002.0375</pub-id></element-citation></ref><ref id="bb0120"><label>24</label><element-citation publication-type="journal" id="rf0120"><person-group person-group-type="author"><name name-style="western"><surname>Chanomethaporn</surname><given-names>A.</given-names></name><name name-style="western"><surname>Chayasadom</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wara-Aswapati</surname><given-names>N.</given-names></name><name name-style="western"><surname>Kongwattanakul</surname><given-names>K.</given-names></name><name name-style="western"><surname>Suwannarong</surname><given-names>W.</given-names></name><name name-style="western"><surname>Tangwanichgapong</surname><given-names>K.</given-names></name><name name-style="western"><surname>Sumanonta</surname><given-names>G.</given-names></name><name name-style="western"><surname>Matangkasombut</surname><given-names>O.</given-names></name><name name-style="western"><surname>Dasanayake</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Pitiphat</surname><given-names>W.</given-names></name></person-group><article-title>Association between periodontitis and spontaneous abortion: A case-control study</article-title><source>J Periodontol</source><year>2018</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/JPER.18-0174</pub-id><pub-id pub-id-type="pmid">30367824</pub-id></element-citation></ref><ref id="bb0125"><label>25</label><element-citation publication-type="journal" id="rf0125"><person-group person-group-type="author"><name name-style="western"><surname>Strauss</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kaplan</surname><given-names>G.G.</given-names></name><name name-style="western"><surname>Beck</surname><given-names>P.L.</given-names></name><name name-style="western"><surname>Rioux</surname><given-names>K.</given-names></name><name name-style="western"><surname>Panaccione</surname><given-names>R.</given-names></name><name name-style="western"><surname>Devinney</surname><given-names>R.</given-names></name><name name-style="western"><surname>Lynch</surname><given-names>T.</given-names></name><name name-style="western"><surname>Allen-Vercoe</surname><given-names>E.</given-names></name></person-group><article-title>Invasive potential of gut mucosa-derived <italic toggle="yes">Fusobacterium nucleatum</italic> positively correlates with IBD status of the host</article-title><source>Inflamm Bowel Dis</source><volume>17</volume><issue>9</issue><year>2011</year><fpage>1971</fpage><lpage>1978</lpage><pub-id pub-id-type="pmid">21830275</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ibd.21606</pub-id></element-citation></ref><ref id="bb0130"><label>26</label><element-citation publication-type="journal" id="rf0130"><person-group person-group-type="author"><name name-style="western"><surname>Sears</surname><given-names>CL</given-names></name></person-group><article-title>The who, where and how of fusobacteria and colon cancer</article-title><source>Elife</source><year>2018</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.7554/eLife.28434</pub-id><pub-id pub-id-type="pmcid">PMC5849411</pub-id><pub-id pub-id-type="pmid">29533185</pub-id></element-citation></ref><ref id="bb0135"><label>27</label><element-citation publication-type="journal" id="rf0135"><person-group person-group-type="author"><name name-style="western"><surname>Bullman</surname><given-names>S.</given-names></name><name name-style="western"><surname>Pedamallu</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Sicinska</surname><given-names>E.</given-names></name><name name-style="western"><surname>Clancy</surname><given-names>T.E.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>D.</given-names></name><name name-style="western"><surname>Neuberg</surname><given-names>D.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>K.</given-names></name><name name-style="western"><surname>Guevara</surname><given-names>F.</given-names></name><name name-style="western"><surname>Nelson</surname><given-names>T.</given-names></name></person-group><article-title>Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer</article-title><source>Science</source><volume>358</volume><issue>6369</issue><year>2017</year><fpage>1443</fpage><lpage>1448</lpage><pub-id pub-id-type="pmid">29170280</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.aal5240</pub-id><pub-id pub-id-type="pmcid">PMC5823247</pub-id></element-citation></ref><ref id="bb0140"><label>28</label><element-citation publication-type="journal" id="rf0140"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>YW</given-names></name></person-group><article-title><italic toggle="yes">Fusobacterium nucleatum</italic>: a commensal-turned pathogen</article-title><source>Curr Opin Microbiol</source><volume>23</volume><year>2015</year><fpage>141</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">25576662</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mib.2014.11.013</pub-id><pub-id pub-id-type="pmcid">PMC4323942</pub-id></element-citation></ref><ref id="bb0145"><label>29</label><element-citation publication-type="journal" id="rf0145"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Baba</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ishimoto</surname><given-names>T.</given-names></name><name name-style="western"><surname>Iwatsuki</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hiyoshi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Miyamoto</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>N.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>R.</given-names></name><name name-style="western"><surname>Baba</surname><given-names>H.</given-names></name></person-group><article-title>Progress in characterizing the linkage between <italic toggle="yes">Fusobacterium nucleatum</italic> and gastrointestinal cancer</article-title><source>J Gastroenterol</source><volume>54</volume><issue>1</issue><year>2019</year><fpage>33</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">30244399</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00535-018-1512-9</pub-id></element-citation></ref><ref id="bb0150"><label>30</label><element-citation publication-type="journal" id="rf0150"><person-group person-group-type="author"><name name-style="western"><surname>Rubinstein</surname><given-names>MR</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W</given-names></name><name name-style="western"><surname>Hao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cai</surname><given-names>G</given-names></name><name name-style="western"><surname>Han</surname><given-names>YW</given-names></name></person-group><article-title><italic toggle="yes">Fusobacterium nucleatum</italic> promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin</article-title><source>Cell Host Microbe</source><volume>14</volume><issue>2</issue><year>2013</year><fpage>195</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">23954158</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chom.2013.07.012</pub-id><pub-id pub-id-type="pmcid">PMC3770529</pub-id></element-citation></ref><ref id="bb0155"><label>31</label><element-citation publication-type="journal" id="rf0155"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>X.</given-names></name></person-group><article-title>Invasive <italic toggle="yes">Fusobacterium nucleatum</italic> activates beta-catenin signaling in colorectal cancer via a TLR4/P-PAK1 cascade</article-title><source>Oncotarget</source><volume>8</volume><issue>19</issue><year>2017</year><fpage>31802</fpage><lpage>31814</lpage><pub-id pub-id-type="pmid">28423670</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18632/oncotarget.15992</pub-id><pub-id pub-id-type="pmcid">PMC5458249</pub-id></element-citation></ref><ref id="bb0160"><label>32</label><element-citation publication-type="journal" id="rf0160"><person-group person-group-type="author"><name name-style="western"><surname>Rubinstein</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Baik</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Lagana</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Han</surname><given-names>R.P.</given-names></name><name name-style="western"><surname>Raab</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Sahoo</surname><given-names>D.</given-names></name><name name-style="western"><surname>Dalerba</surname><given-names>P.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>T.C.</given-names></name><name name-style="western"><surname>Han</surname><given-names>Y.W.</given-names></name></person-group><article-title><italic toggle="yes">Fusobacterium nucleatum</italic> promotes colorectal cancer by inducing Wnt/beta-catenin modulator Annexin A1</article-title><source>EMBO Rep</source><year>2019</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/embr.201847638</pub-id><pub-id pub-id-type="pmcid">PMC6446206</pub-id><pub-id pub-id-type="pmid">30833345</pub-id></element-citation></ref><ref id="bb0165"><label>33</label><element-citation publication-type="journal" id="rf0165"><person-group person-group-type="author"><name name-style="western"><surname>Vander Haar</surname><given-names>EL</given-names></name><name name-style="western"><surname>So</surname><given-names>J</given-names></name><name name-style="western"><surname>Gyamfi-Bannerman</surname><given-names>C</given-names></name><name name-style="western"><surname>Han</surname><given-names>YW</given-names></name></person-group><article-title><italic toggle="yes">Fusobacterium nucleatum</italic> and adverse pregnancy outcomes: Epidemiological and mechanistic evidence</article-title><source>Anaerobe</source><volume>50</volume><year>2018</year><fpage>55</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">29409815</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.anaerobe.2018.01.008</pub-id><pub-id pub-id-type="pmcid">PMC6750227</pub-id></element-citation></ref><ref id="bb0170"><label>34</label><element-citation publication-type="journal" id="rf0170"><person-group person-group-type="author"><name name-style="western"><surname>Fardini</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Temoin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Nithianantham</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>D.</given-names></name><name name-style="western"><surname>Shoham</surname><given-names>M.</given-names></name><name name-style="western"><surname>Han</surname><given-names>Y.W.</given-names></name></person-group><article-title><italic toggle="yes">Fusobacterium nucleatum</italic> adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity</article-title><source>Mol Microbiol</source><volume>82</volume><issue>6</issue><year>2011</year><fpage>1468</fpage><lpage>1480</lpage><pub-id pub-id-type="pmid">22040113</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2958.2011.07905.x</pub-id><pub-id pub-id-type="pmcid">PMC3237733</pub-id></element-citation></ref><ref id="bb0175"><label>35</label><element-citation publication-type="journal" id="rf0175"><person-group person-group-type="author"><name name-style="western"><surname>Hashemi Goradel</surname><given-names>N.</given-names></name><name name-style="western"><surname>Heidarzadeh</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jahangiri</surname><given-names>S.</given-names></name><name name-style="western"><surname>Farhood</surname><given-names>B.</given-names></name><name name-style="western"><surname>Mortezaee</surname><given-names>K.</given-names></name><name name-style="western"><surname>Khanlarkhani</surname><given-names>N.</given-names></name><name name-style="western"><surname>Negahdari</surname><given-names>B.</given-names></name></person-group><article-title><italic toggle="yes">Fusobacterium nucleatum</italic> and colorectal cancer: A mechanistic overview</article-title><source>J Cell Physiol</source><volume>234</volume><issue>3</issue><year>2019</year><fpage>2337</fpage><lpage>2344</lpage><pub-id pub-id-type="pmid">30191984</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jcp.27250</pub-id></element-citation></ref><ref id="bb0180"><label>36</label><element-citation publication-type="journal" id="rf0180"><person-group person-group-type="author"><name name-style="western"><surname>Kaplan</surname><given-names>C.W.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>X.</given-names></name><name name-style="western"><surname>Paranjpe</surname><given-names>A.</given-names></name><name name-style="western"><surname>Jewett</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lux</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kinder-Haake</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>W.</given-names></name></person-group><article-title><italic toggle="yes">Fusobacterium nucleatum</italic> outer membrane proteins Fap2 and RadD induce cell death in human lymphocytes</article-title><source>Infect Immun</source><volume>78</volume><issue>11</issue><year>2010</year><fpage>4773</fpage><lpage>4778</lpage><pub-id pub-id-type="pmid">20823215</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.00567-10</pub-id><pub-id pub-id-type="pmcid">PMC2976331</pub-id></element-citation></ref><ref id="bb0185"><label>37</label><element-citation publication-type="journal" id="rf0185"><person-group person-group-type="author"><name name-style="western"><surname>Abed</surname><given-names>J.</given-names></name><name name-style="western"><surname>Emgard</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Zamir</surname><given-names>G.</given-names></name><name name-style="western"><surname>Faroja</surname><given-names>M.</given-names></name><name name-style="western"><surname>Almogy</surname><given-names>G.</given-names></name><name name-style="western"><surname>Grenov</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sol</surname><given-names>A.</given-names></name><name name-style="western"><surname>Naor</surname><given-names>R.</given-names></name><name name-style="western"><surname>Pikarsky</surname><given-names>E.</given-names></name><name name-style="western"><surname>Atlan</surname><given-names>K.A.</given-names></name></person-group><article-title>Fap2 mediates <italic toggle="yes">Fusobacterium nucleatum</italic> colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc</article-title><source>Cell Host Microbe</source><volume>20</volume><issue>2</issue><year>2016</year><fpage>215</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">27512904</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chom.2016.07.006</pub-id><pub-id pub-id-type="pmcid">PMC5465824</pub-id></element-citation></ref><ref id="bb0190"><label>38</label><element-citation publication-type="journal" id="rf0190"><person-group person-group-type="author"><name name-style="western"><surname>Kaplan</surname><given-names>CW</given-names></name><name name-style="western"><surname>Lux</surname><given-names>R</given-names></name><name name-style="western"><surname>Haake</surname><given-names>SK</given-names></name><name name-style="western"><surname>Shi</surname><given-names>W</given-names></name></person-group><article-title>The <italic toggle="yes">Fusobacterium nucleatum</italic> outer membrane protein RadD is an arginine-inhibitable adhesin required for inter-species adherence and the structured architecture of multispecies biofilm</article-title><source>Mol Microbiol</source><volume>71</volume><issue>1</issue><year>2009</year><fpage>35</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">19007407</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2958.2008.06503.x</pub-id><pub-id pub-id-type="pmcid">PMC2741168</pub-id></element-citation></ref><ref id="bb0195"><label>39</label><element-citation publication-type="journal" id="rf0195"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name></person-group><article-title>Invasive <italic toggle="yes">Fusobacterium nucleatum</italic> may play a role in the carcinogenesis of proximal colon cancer through the serrated neoplasia pathway</article-title><source>Int J Cancer</source><volume>139</volume><issue>6</issue><year>2016</year><fpage>1318</fpage><lpage>1326</lpage><pub-id pub-id-type="pmid">27130618</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ijc.30168</pub-id></element-citation></ref><ref id="bb0200"><label>40</label><element-citation publication-type="journal" id="rf0200"><person-group person-group-type="author"><name name-style="western"><surname>Brennan</surname><given-names>CA</given-names></name><name name-style="western"><surname>Garrett</surname><given-names>WS</given-names></name></person-group><article-title>Gut microbiota, inflammation, and colorectal cancer</article-title><source>Annu Rev Microbiol</source><volume>70</volume><year>2016</year><fpage>395</fpage><lpage>411</lpage><pub-id pub-id-type="pmid">27607555</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev-micro-102215-095513</pub-id><pub-id pub-id-type="pmcid">PMC5541233</pub-id></element-citation></ref><ref id="bb0205"><label>41</label><element-citation publication-type="journal" id="rf0205"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>B.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>K.</given-names></name><name name-style="western"><surname>Jia</surname><given-names>Y.P.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>P.</given-names></name><name name-style="western"><surname>Fang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z.J.</given-names></name><name name-style="western"><surname>Mao</surname><given-names>X.H.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>D.Z.</given-names></name></person-group><article-title><italic toggle="yes">Fusobacterium nucleatum</italic>-induced impairment of autophagic flux enhances the expression of proinflammatory cytokines via ROS in Caco-2 cells</article-title><source>PLoS One</source><volume>11</volume><issue>11</issue><year>2016</year><object-id pub-id-type="publisher-id">e0165701</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0165701</pub-id><pub-id pub-id-type="pmcid">PMC5102440</pub-id><pub-id pub-id-type="pmid">27828984</pub-id></element-citation></ref><ref id="bb0210"><label>42</label><element-citation publication-type="journal" id="rf0210"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Okugawa</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Han</surname><given-names>H.</given-names></name></person-group><article-title>Novel evidence for an oncogenic role of microRNA-21 in colitis-associated colorectal cancer</article-title><source>Gut</source><volume>65</volume><issue>9</issue><year>2016</year><fpage>1470</fpage><lpage>1481</lpage><pub-id pub-id-type="pmid">25994220</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gutjnl-2014-308455</pub-id></element-citation></ref><ref id="bb0215"><label>43</label><element-citation publication-type="journal" id="rf0215"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>H.F.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.F.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Q.Y.</given-names></name><name name-style="western"><surname>Ning</surname><given-names>F.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W.L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>G.</given-names></name></person-group><article-title>Evaluation of antibody level against <italic toggle="yes">Fusobacterium nucleatum</italic> in the serological diagnosis of colorectal cancer</article-title><source>Sci Rep</source><volume>6</volume><year>2016</year><object-id pub-id-type="publisher-id">33440</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/srep33440</pub-id><pub-id pub-id-type="pmcid">PMC5039407</pub-id><pub-id pub-id-type="pmid">27678333</pub-id></element-citation></ref><ref id="bb0220"><label>44</label><element-citation publication-type="journal" id="rf0220"><person-group person-group-type="author"><name name-style="western"><surname>Kostic</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Chun</surname><given-names>E.</given-names></name><name name-style="western"><surname>Robertson</surname><given-names>L.</given-names></name><name name-style="western"><surname>Glickman</surname><given-names>J.N.</given-names></name><name name-style="western"><surname>Gallini</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Michaud</surname><given-names>M.</given-names></name><name name-style="western"><surname>Clancy</surname><given-names>T.E.</given-names></name><name name-style="western"><surname>Chung</surname><given-names>D.C.</given-names></name><name name-style="western"><surname>Lochhead</surname><given-names>P.</given-names></name><name name-style="western"><surname>Hold</surname><given-names>G.L.</given-names></name></person-group><article-title><italic toggle="yes">Fusobacterium nucleatum</italic> potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment</article-title><source>Cell Host Microbe</source><volume>14</volume><issue>2</issue><year>2013</year><fpage>207</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">23954159</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chom.2013.07.007</pub-id><pub-id pub-id-type="pmcid">PMC3772512</pub-id></element-citation></ref><ref id="bb0225"><label>45</label><element-citation publication-type="journal" id="rf0225"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Han</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Jeong</surname><given-names>Y.J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>T.H.</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>S.G.</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>J.H.</given-names></name></person-group><article-title>Diverse Toll-like receptors mediate cytokine production by <italic toggle="yes">Fusobacterium nucleatum</italic> and <italic toggle="yes">Aggregatibacter actinomycetemcomitans</italic> in macrophages</article-title><source>Infect Immun</source><volume>82</volume><issue>5</issue><year>2014</year><fpage>1914</fpage><lpage>1920</lpage><pub-id pub-id-type="pmid">24566622</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.01226-13</pub-id><pub-id pub-id-type="pmcid">PMC3993440</pub-id></element-citation></ref><ref id="bb0230"><label>46</label><element-citation publication-type="journal" id="rf0230"><person-group person-group-type="author"><name name-style="western"><surname>Noh</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Jeong</surname><given-names>Y.J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Oh</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>K.B.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Shin</surname><given-names>J.A.</given-names></name></person-group><article-title>Withaferin A inhibits inflammatory responses induced by <italic toggle="yes">Fusobacterium nucleatum</italic> and <italic toggle="yes">Aggregatibacter actinomycetemcomitans</italic> in macrophages</article-title><source>Mol Med Rep</source><volume>14</volume><issue>1</issue><year>2016</year><fpage>983</fpage><lpage>988</lpage><pub-id pub-id-type="pmid">27220676</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3892/mmr.2016.5326</pub-id></element-citation></ref><ref id="bb0235"><label>47</label><element-citation publication-type="journal" id="rf0235"><person-group person-group-type="author"><name name-style="western"><surname>Dharmani</surname><given-names>P</given-names></name><name name-style="western"><surname>Strauss</surname><given-names>J</given-names></name><name name-style="western"><surname>Ambrose</surname><given-names>C</given-names></name><name name-style="western"><surname>Allen-Vercoe</surname><given-names>E</given-names></name><name name-style="western"><surname>Chadee</surname><given-names>K</given-names></name></person-group><article-title><italic toggle="yes">Fusobacterium nucleatum</italic> infection of colonic cells stimulates MUC2 mucin and tumor necrosis factor alpha</article-title><source>Infect Immun</source><volume>79</volume><issue>7</issue><year>2011</year><fpage>2597</fpage><lpage>2607</lpage><pub-id pub-id-type="pmid">21536792</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.05118-11</pub-id><pub-id pub-id-type="pmcid">PMC3191979</pub-id></element-citation></ref><ref id="bb0240"><label>48</label><element-citation publication-type="journal" id="rf0240"><person-group person-group-type="author"><name name-style="western"><surname>Bashir</surname><given-names>A</given-names></name><name name-style="western"><surname>Miskeen</surname><given-names>AY</given-names></name><name name-style="western"><surname>Hazari</surname><given-names>YM</given-names></name><name name-style="western"><surname>Asrafuzzaman</surname><given-names>S</given-names></name><name name-style="western"><surname>Fazili</surname><given-names>KM</given-names></name></person-group><article-title><italic toggle="yes">Fusobacterium nucleatum</italic>, inflammation, and immunity: the fire within human gut</article-title><source>Tumour Biol</source><volume>37</volume><issue>3</issue><year>2016</year><fpage>2805</fpage><lpage>2810</lpage><pub-id pub-id-type="pmid">26718210</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s13277-015-4724-0</pub-id></element-citation></ref><ref id="bb0245"><label>49</label><element-citation publication-type="journal" id="rf0245"><person-group person-group-type="author"><name name-style="western"><surname>Keku</surname><given-names>TO</given-names></name><name name-style="western"><surname>McCoy</surname><given-names>AN</given-names></name><name name-style="western"><surname>Azcarate-Peril</surname><given-names>AM</given-names></name></person-group><article-title>Fusobacterium spp. and colorectal cancer: cause or consequence?</article-title><source>Trends Microbiol</source><volume>21</volume><issue>10</issue><year>2013</year><fpage>506</fpage><lpage>508</lpage><pub-id pub-id-type="pmid">24029382</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tim.2013.08.004</pub-id><pub-id pub-id-type="pmcid">PMC3836616</pub-id></element-citation></ref><ref id="bb0250"><label>50</label><element-citation publication-type="journal" id="rf0250"><person-group person-group-type="author"><name name-style="western"><surname>Edin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wikberg</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Dahlin</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Rutegard</surname><given-names>J.</given-names></name><name name-style="western"><surname>Oberg</surname><given-names>A.</given-names></name><name name-style="western"><surname>Oldenborg</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Palmqvist</surname><given-names>R.</given-names></name></person-group><article-title>The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer</article-title><source>PLoS One</source><volume>7</volume><issue>10</issue><year>2012</year><object-id pub-id-type="publisher-id">e47045</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0047045</pub-id><pub-id pub-id-type="pmcid">PMC3471949</pub-id><pub-id pub-id-type="pmid">23077543</pub-id></element-citation></ref><ref id="bb0255"><label>51</label><element-citation publication-type="journal" id="rf0255"><person-group person-group-type="author"><name name-style="western"><surname>Edin</surname><given-names>S</given-names></name><name name-style="western"><surname>Wikberg</surname><given-names>ML</given-names></name><name name-style="western"><surname>Oldenborg</surname><given-names>PA</given-names></name><name name-style="western"><surname>Palmqvist</surname><given-names>R</given-names></name></person-group><article-title>Macrophages: Good guys in colorectal cancer</article-title><source>Oncoimmunology</source><volume>2</volume><issue>2</issue><year>2013</year><object-id pub-id-type="publisher-id">e23038</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4161/onci.23038</pub-id><pub-id pub-id-type="pmcid">PMC3601174</pub-id><pub-id pub-id-type="pmid">23524684</pub-id></element-citation></ref><ref id="bb0260"><label>52</label><element-citation publication-type="journal" id="rf0260"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>W.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Weng</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>M.</given-names></name></person-group><article-title>MFHAS1 promotes colorectal cancer progress by regulating polarization of tumor-associated macrophages via STAT6 signaling pathway</article-title><source>Oncotarget</source><volume>7</volume><issue>48</issue><year>2016</year><fpage>78726</fpage><lpage>78735</lpage><pub-id pub-id-type="pmid">27783989</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18632/oncotarget.12807</pub-id><pub-id pub-id-type="pmcid">PMC5346672</pub-id></element-citation></ref><ref id="bb0265"><label>53</label><element-citation publication-type="journal" id="rf0265"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>T.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>W.</given-names></name><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>X.</given-names></name></person-group><article-title><italic toggle="yes">Fusobacterium nucleatum</italic> promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism</article-title><source>Cancer Immunol Immunother</source><volume>67</volume><issue>10</issue><year>2018</year><fpage>1635</fpage><lpage>1646</lpage><pub-id pub-id-type="pmid">30121899</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00262-018-2233-x</pub-id><pub-id pub-id-type="pmcid">PMC11028377</pub-id></element-citation></ref><ref id="bb0270"><label>54</label><element-citation publication-type="journal" id="rf0270"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>HE</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JH</given-names></name><name name-style="western"><surname>Cho</surname><given-names>NY</given-names></name><name name-style="western"><surname>Lee</surname><given-names>HS</given-names></name><name name-style="western"><surname>Kang</surname><given-names>GH</given-names></name></person-group><article-title>Intratumoral <italic toggle="yes">Fusobacterium nucleatum</italic> abundance correlates with macrophage infiltration and CDKN2A methylation in microsatellite-unstable colorectal carcinoma</article-title><source>Virchows Arch</source><volume>471</volume><issue>3</issue><year>2017</year><fpage>329</fpage><lpage>336</lpage><pub-id pub-id-type="pmid">28597080</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00428-017-2171-6</pub-id></element-citation></ref><ref id="bb0275"><label>55</label><element-citation publication-type="journal" id="rf0275"><person-group person-group-type="author"><name name-style="western"><surname>Xue</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>H.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Liao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>G.</given-names></name></person-group><article-title>Indoleamine 2,3-dioxygenase expression regulates the survival and proliferation of <italic toggle="yes">Fusobacterium nucleatum</italic> in THP-1-derived macrophages</article-title><source>Cell Death Dis</source><volume>9</volume><issue>3</issue><year>2018</year><fpage>355</fpage><pub-id pub-id-type="pmid">29500439</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41419-018-0389-0</pub-id><pub-id pub-id-type="pmcid">PMC5834448</pub-id></element-citation></ref><ref id="bb0280"><label>56</label><element-citation publication-type="journal" id="rf0280"><person-group person-group-type="author"><name name-style="western"><surname>Abe</surname><given-names>K</given-names></name></person-group><article-title>Butyric acid induces apoptosis in both human monocytes and lymphocytes equivalently</article-title><source>J Oral Sci</source><volume>54</volume><issue>1</issue><year>2012</year><fpage>7</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">22466881</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2334/josnusd.54.7</pub-id></element-citation></ref><ref id="bb0285"><label>57</label><element-citation publication-type="journal" id="rf0285"><person-group person-group-type="author"><name name-style="western"><surname>Gur</surname><given-names>C.</given-names></name><name name-style="western"><surname>Ibrahim</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Isaacson</surname><given-names>B.</given-names></name><name name-style="western"><surname>Yamin</surname><given-names>R.</given-names></name><name name-style="western"><surname>Abed</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gamliel</surname><given-names>M.</given-names></name><name name-style="western"><surname>Enk</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bar-On</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Stanietsky-Kaynan</surname><given-names>N.</given-names></name><name name-style="western"><surname>Coppenhagen-Glazer</surname><given-names>S.</given-names></name></person-group><article-title>Binding of the Fap2 protein of <italic toggle="yes">Fusobacterium nucleatum</italic> to human inhibitory receptor TIGIT protects tumors from immune cell attack</article-title><source>Immunity</source><volume>42</volume><issue>2</issue><year>2015</year><fpage>344</fpage><lpage>355</lpage><pub-id pub-id-type="pmid">25680274</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2015.01.010</pub-id><pub-id pub-id-type="pmcid">PMC4361732</pub-id></element-citation></ref><ref id="bb0290"><label>58</label><element-citation publication-type="journal" id="rf0290"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>T.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Long</surname><given-names>R.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>X.</given-names></name></person-group><article-title>TOX expression decreases with progression of colorectal cancers and is associated with CD4 T-cell density and <italic toggle="yes">Fusobacterium nucleatum</italic> infection</article-title><source>Hum Pathol</source><volume>79</volume><year>2018</year><fpage>93</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">29792893</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.humpath.2018.05.008</pub-id></element-citation></ref><ref id="bb0295"><label>59</label><element-citation publication-type="journal" id="rf0295"><person-group person-group-type="author"><name name-style="western"><surname>Huynh</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kapur</surname><given-names>R.V.</given-names></name><name name-style="western"><surname>Kaplan</surname><given-names>C.W.</given-names></name><name name-style="western"><surname>Cacalano</surname><given-names>N.</given-names></name><name name-style="western"><surname>Kinder Haake</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>W.</given-names></name><name name-style="western"><surname>Sieling</surname><given-names>P.</given-names></name><name name-style="western"><surname>Jewett</surname><given-names>A.</given-names></name></person-group><article-title>The role of aggregation in <italic toggle="yes">Fusobacterium nucleatum</italic>-induced immune cell death</article-title><source>J Endod</source><volume>37</volume><issue>11</issue><year>2011</year><fpage>1531</fpage><lpage>1535</lpage><pub-id pub-id-type="pmid">22000457</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.joen.2011.06.034</pub-id></element-citation></ref><ref id="bb0300"><label>60</label><element-citation publication-type="journal" id="rf0300"><person-group person-group-type="author"><name name-style="western"><surname>Shenker</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Datar</surname><given-names>S</given-names></name></person-group><article-title><italic toggle="yes">Fusobacterium nucleatum</italic> inhibits human T-cell activation by arresting cells in the mid-G1 phase of the cell cycle</article-title><source>Infect Immun</source><volume>63</volume><issue>12</issue><year>1995</year><fpage>4830</fpage><lpage>4836</lpage><pub-id pub-id-type="pmid">7591143</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.63.12.4830-4836.1995</pub-id><pub-id pub-id-type="pmcid">PMC173692</pub-id></element-citation></ref><ref id="bb0305"><label>61</label><element-citation publication-type="journal" id="rf0305"><person-group person-group-type="author"><name name-style="western"><surname>Shenker</surname><given-names>BJ</given-names></name><name name-style="western"><surname>DiRienzo</surname><given-names>JM</given-names></name></person-group><article-title>Suppression of human peripheral blood lymphocytes by <italic toggle="yes">Fusobacterium nucleatum</italic></article-title><source>J Immunol</source><volume>132</volume><issue>5</issue><year>1984</year><fpage>2357</fpage><lpage>2362</lpage><pub-id pub-id-type="pmid">6715883</pub-id></element-citation></ref><ref id="bb0310"><label>62</label><element-citation publication-type="journal" id="rf0310"><person-group person-group-type="author"><name name-style="western"><surname>Hamada</surname><given-names>T.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Mima</surname><given-names>K.</given-names></name><name name-style="western"><surname>Bullman</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sukawa</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Nowak</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Kosumi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Masugi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Twombly</surname><given-names>T.S.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y.</given-names></name></person-group><article-title><italic toggle="yes">Fusobacterium nucleatum</italic> in colorectal cancer relates to immune response differentially by tumor microsatellite instability status</article-title><source>Cancer Immunol Res</source><volume>6</volume><issue>11</issue><year>2018</year><fpage>1327</fpage><lpage>1336</lpage><pub-id pub-id-type="pmid">30228205</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/2326-6066.CIR-18-0174</pub-id><pub-id pub-id-type="pmcid">PMC6215508</pub-id></element-citation></ref><ref id="bb0315"><label>63</label><element-citation publication-type="journal" id="rf0315"><person-group person-group-type="author"><name name-style="western"><surname>Gabrilovich</surname><given-names>DI</given-names></name><name name-style="western"><surname>Ostrand-Rosenberg</surname><given-names>S</given-names></name><name name-style="western"><surname>Bronte</surname><given-names>V</given-names></name></person-group><article-title>Coordinated regulation of myeloid cells by tumours</article-title><source>Nat Rev Immunol</source><volume>12</volume><issue>4</issue><year>2012</year><fpage>253</fpage><lpage>268.64</lpage><pub-id pub-id-type="pmid">22437938</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nri3175</pub-id><pub-id pub-id-type="pmcid">PMC3587148</pub-id></element-citation></ref><ref id="bb0320"><label>64</label><element-citation publication-type="journal" id="rf0320"><person-group person-group-type="author"><name name-style="western"><surname>Ye</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bhattacharya</surname><given-names>R.</given-names></name><name name-style="western"><surname>Boulbes</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>F.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>L.</given-names></name><name name-style="western"><surname>Adoni</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ajami</surname><given-names>N.J.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>D.P.</given-names></name></person-group><article-title><italic toggle="yes">Fusobacterium nucleatum</italic> subspecies animalis influences proinflammatory cytokine expression and monocyte activation in human colorectal tumors</article-title><source>Cancer Prev Res (Phila)</source><volume>10</volume><issue>7</issue><year>2017</year><fpage>398</fpage><lpage>409.65</lpage><pub-id pub-id-type="pmid">28483840</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/1940-6207.CAPR-16-0178</pub-id></element-citation></ref><ref id="bb0325"><label>65</label><element-citation publication-type="journal" id="rf0325"><person-group person-group-type="author"><name name-style="western"><surname>Stanietsky</surname><given-names>N.</given-names></name><name name-style="western"><surname>Simic</surname><given-names>H.</given-names></name><name name-style="western"><surname>Arapovic</surname><given-names>J.</given-names></name><name name-style="western"><surname>Toporik</surname><given-names>A.</given-names></name><name name-style="western"><surname>Levy</surname><given-names>O.</given-names></name><name name-style="western"><surname>Novik</surname><given-names>A.</given-names></name><name name-style="western"><surname>Levine</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Beiman</surname><given-names>M.</given-names></name><name name-style="western"><surname>Dassa</surname><given-names>L.</given-names></name><name name-style="western"><surname>Achdout</surname><given-names>H.</given-names></name></person-group><article-title>The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity</article-title><source>Proc Natl Acad Sci U S A</source><volume>106</volume><issue>42</issue><year>2009</year><fpage>17858</fpage><lpage>17863</lpage><pub-id pub-id-type="pmid">19815499</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0903474106</pub-id><pub-id pub-id-type="pmcid">PMC2764881</pub-id></element-citation></ref><ref id="bb0330"><label>66</label><element-citation publication-type="journal" id="rf0330"><person-group person-group-type="author"><name name-style="western"><surname>Guevarra</surname><given-names>L.A.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Afable</surname><given-names>A.C.F.</given-names></name><name name-style="western"><surname>Belza</surname><given-names>P.J.O.</given-names></name><name name-style="western"><surname>Dy</surname><given-names>K.J.S.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.J.Q.</given-names></name><name name-style="western"><surname>Sy-Ortin</surname><given-names>T.T.</given-names></name><name name-style="western"><surname>Albano</surname><given-names>P.</given-names></name></person-group><article-title>Immunogenicity of a Fap2 peptide mimotope of <italic toggle="yes">Fusobacterium nucleatum</italic> and its potential use in the diagnosis of colorectal cancer</article-title><source>Infect Agent Cancer</source><volume>13</volume><year>2018</year><fpage>11</fpage><pub-id pub-id-type="pmid">29619076</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13027-018-0184-7</pub-id><pub-id pub-id-type="pmcid">PMC5879760</pub-id></element-citation></ref><ref id="bb0335"><label>67</label><element-citation publication-type="journal" id="rf0335"><person-group person-group-type="author"><name name-style="western"><surname>Coombes</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Siddiqui</surname><given-names>K.R.</given-names></name><name name-style="western"><surname>Arancibia-Carcamo</surname><given-names>C.V.</given-names></name><name name-style="western"><surname>Hall</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Belkaid</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Powrie</surname><given-names>F.</given-names></name></person-group><article-title>A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism</article-title><source>J Exp Med</source><volume>204</volume><issue>8</issue><year>2007</year><fpage>1757</fpage><lpage>1764</lpage><pub-id pub-id-type="pmid">17620361</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20070590</pub-id><pub-id pub-id-type="pmcid">PMC2118683</pub-id></element-citation></ref><ref id="bb0340"><label>68</label><element-citation publication-type="journal" id="rf0340"><person-group person-group-type="author"><name name-style="western"><surname>Mantovani</surname><given-names>A</given-names></name><name name-style="western"><surname>Cassatella</surname><given-names>MA</given-names></name><name name-style="western"><surname>Costantini</surname><given-names>C</given-names></name><name name-style="western"><surname>Jaillon</surname><given-names>S</given-names></name></person-group><article-title>Neutrophils in the activation and regulation of innate and adaptive immunity</article-title><source>Nat Rev Immunol</source><volume>11</volume><issue>8</issue><year>2011</year><fpage>519</fpage><lpage>531</lpage><pub-id pub-id-type="pmid">21785456</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nri3024</pub-id></element-citation></ref><ref id="bb0345"><label>69</label><element-citation publication-type="journal" id="rf0345"><person-group person-group-type="author"><name name-style="western"><surname>Rao</surname><given-names>H.L.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Li</surname><given-names>M.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Y.B.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Y.X.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>M.Y.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>D.</given-names></name></person-group><article-title>Increased intratumoral neutrophil in colorectal carcinomas correlates closely with malignant phenotype and predicts patients' adverse prognosis</article-title><source>PLoS One</source><volume>7</volume><issue>1</issue><year>2012</year><object-id pub-id-type="publisher-id">e30806</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0030806</pub-id><pub-id pub-id-type="pmcid">PMC3266280</pub-id><pub-id pub-id-type="pmid">22295111</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>